[ad_1]
WASHINGTON, DC – September 30, 2021 (Investorideas.com Newswire) On Thursday, the House Judiciary Committee approved a bill that would remove cannabis from the list of controlled substances and end the conflict between the state and the federal government which currently exists in the majority of states that have regulated cannabis in one way or another. The Marijuana Opportunities, Reinvestment, and Suppression Act (MORE), or HR 3617, was reintroduced by House Judiciary President Jerrold Nadler (D-NY) and has 74 cosponsors.
In addition to removing cannabis from the Controlled Substances Act, the bill would overturn non-violent federal cannabis convictions and support state efforts to do the same, provide opportunities and resources for cannabis companies owned by the United States. women and people of color, create reinvestment programs for communities that have been affected by prohibition, improve immigration laws related to cannabis, and allow doctors in the Veterans Affairs system to recommend medical cannabis to their families. patients.
The MORE law was initially approved in a plenary vote in December 2020, becoming the first bill to end the federal ban from being passed in either house. A companion bill was introduced in the Senate by current Vice President Kamala Harris, but was not heard until the end of the session.
Current legislation must be reviewed or overturned by several other competence committees before it can be put to another tiered vote.
“We are grateful that the House continues to pursue sensible cannabis policy reforms and once again move forward on this important bill,” said Aaron Smith, co-founder and CEO of the National Cannabis Industry Association ( NCIA). “While the MORE Act does not have the strong regulatory structure that we would like to see in a comprehensive deprogramming bill, it does represent the growing support for an end to the ban among lawmakers and the American public, let alone current policies of dozens of states across the country. . “
“This bill would be a huge improvement over the status quo and help advance the conversation about what an effective federal cannabis policy looks like,” Smith continued. “Removing cannabis from the Controlled Substance Act is absolutely necessary, and the MORE Act would be a big step in the right direction for restorative justice and ensure that small businesses and members of marginalized communities who have been disproportionately harmed by prohibition can benefit from the opportunities created by regulated cannabis markets.
The NCIA initially released recommendations for a federal regulatory framework in October 2019 and worked with lawmakers to include them in comprehensive cannabis policy reform bills. Many of these ideas were incorporated into the draft Cannabis Administration and Opportunity Act, which was released in July by Senate Majority Leader Chuck Schumer (D-NY) and Senators Cory Booker (D- NJ) and Ron Wyden (D-OR). The NCIA has provided important input developed with members and stakeholders from across the cannabis industry and will continue to work with sponsors to pass legislation that repairs as much as possible the damage caused by prohibition, protects small businesses and ensures that a well-regulated cannabis industry can reach its full potential in the United States.
Laws to legalize cannabis for adults have been passed in 19 states as well as the District of Columbia and the territories of CNMI and Guam, and 36 states as well as several territories have comprehensive medical cannabis laws. The substance is legal in one form or another in 47 states.
The National Cannabis Industry Association (NCIA) is the largest cannabis trade association in the United States and the only organization broadly representing cannabis-related businesses nationally. The NCIA promotes the growth of a responsible and legitimate cannabis industry and strives to create a favorable social, economic and legal environment for this industry in the United States.
Disclaimer / Disclosure: Investorideas.com is a digital publisher of third party equity news, articles and research and creates original content including videos, interviews and articles. Original content created by Investorideas is protected by copyright laws other than syndication rights. Our site does not make any recommendations to buy or sell any stock, service or product. Nothing on our sites should be construed as an offer or a solicitation to buy or sell any products or securities. Any investment involves risks and possible losses. This site is currently paid for news publishing and distribution, social media and marketing, content creation and more. Disclosure is issued for every paid press release, content posted / created as necessary, but otherwise the news has not been paid and has been published for the sole benefit of our readers and subscribers. Contact the management and IR of each company directly for specific questions.
More information on the disclaimer: https://www.investorideas.com/About/Disclaimer.asp Learn more about posting your press release and our other news feed services press Investorideas.com https://www.investorideas.com/News-Upload / and tickertagstocknews.com
Global investors must follow the regulations of each country. Please read the Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Buy a guest article on cannabis at Investorideas.com
[ad_2]
